1-8 of 8
Marcelo Pitombeira de Lacerda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial

Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Aparecida Martinez, Anna Maria Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios Dimopoulos, Chengcheng Fu, Mamta Garg, Al-Ola Abdallah, Moshe E Gatt, Albert Oriol, Michele Cavo, Robert Rifkin, Tomoaki Fujisaki, Michał Mielnik, Nick Pirooz, Joe Lee, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Maria Victoria Mateos
Journal: Blood
Blood (2024) 144 (Supplement 1): 772.
https://doi.org/10.1182/blood-2024-200336
Published: 2024
Journal Articles

Efficacy Outcomes By Minimal Residual Disease (MRD) Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated with Belantamab Mafodotin Plus Bortezomib and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone: Analysis from the Dreamm-7 Trial

Vania Hungria, Marek Hus, Pawel Robak, Vera Zherebtsova, Ana Carolina de Almeida Ribas, Marcelo Pitombeira de Lacerda, Kihyun Kim, Sebastian Grosicki, Irwindeep Sandhu, Christopher Ward, Astrid McKeown, Hena Baig, Jie Ma, Benjamin Lariviere, Benga Kazeem, Lydia Eccersley, Sumita Roy-Ghanta, Joanna Opalinska, Maria Victoria Mateos
Journal: Blood
Blood (2024) 144 (Supplement 1): 3359.
https://doi.org/10.1182/blood-2024-201543
Published: 2024
Journal Articles

Safety and Efficacy of Venetoclax, Cytarabine and Metformin for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia

Marcelo Pitombeira de Lacerda, Elenaide Nunes, Giovanna Steffenello, Thiago Xavier Carneiro, Ivan Schneider Boettcher, Ana Claudia Dall'Oglio, Fernanda Martini, Leonardo Esmeraldino, Mayara Molossi, Andressa Oliveira Martin Wagner, Ederson Roberto Mattos, Celso Arrais-Rodrigues
Journal: Blood
Blood (2024) 144 (Supplement 1): 1524.
https://doi.org/10.1182/blood-2024-210847
Published: 2024
Journal Articles

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Luis Mario Villela Martinez, Brady Beltran, Alberto Villalobos Prieto, Ana Carolina Oliver, Marcela Elizabeth Zamora Matute, Maria Alejandra Torres Viera, Alana Von Glasenapp, Yusaima Rodriguez-Fraga, Sr., Victoria Irigoin, Sabrina Ranero Ferrari, Maria Orlova, German R. Stemmelin, Sr., Sofía Gabriela Rivarola, Adrían Alejandro Ceballos López, Jorge Montemayor, Martha Alvarado Ibarra, Alonso Hernandez, Daniela De Jesus Perez Samano, Álvaro Cabrera García, Natalia Pin Chuen Zing, Myrna Candelaria, Henry Idrobo, Guilherme Fleury Perini, Rosa Oliday, Breno Gusmao, Juan Daniel Garza Escobar, Jr., Marcelo Pitombeira de Lacerda, Sally Paredes, Virginia Lema Spinelli, Humberto Martinez-Cordero, Rafael Martin De Jesus Pichardo Rodriguez, Luis Enrique Malpica Castillo, Jorge J. Castillo
Journal: Blood
Blood (2024) 144 (Supplement 1): 1718.
https://doi.org/10.1182/blood-2024-211584
Published: 2024
Journal Articles

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Marcelo Pitombeira de Lacerda, Fernanda de Morais Marques, Verena Pfister, Flavia de Carvalho Parra, Vinicius Campos de Molla, Valeria Buccheri, Rafael Dezen Gaiolla, Laura Maria Fogliatto, Rodrigo Santucci, Marcelo Bellesso, Sérgio Costa Fortier, Talita M.B. Silveira, Glaciano Ribeiro, Nelson Hamerschlak, Mihoko Yamamoto, Matheus Vescovi Goncalves, Carlos S. Chiattone, Celso Arrais-Rodrigues
Journal: Blood
Blood (2022) 140 (Supplement 1): 7041–7042.
https://doi.org/10.1182/blood-2022-170872
Published: 2022
Journal Articles

Hematology Referral, Stroke Recurrence and Mortality Among Patients with First Ischemic Stroke and Polycythemia or Thrombocytosis

Marcelo Pitombeira de Lacerda, Aline da Silva Tezotto, Yves Gabriel Souza Roussenq, Carolina Werner, Gabriela da Costa Werlang, Iohana Vitória Dalri, Joao Pedro Ribeiro Baptista, Fernanda de Morais Marques, Juliana Safanelli, Vivian Nagel, Paulo Henrique Condeixa de Franca, Alexandre Luis Longo
Journal: Blood
Blood (2022) 140 (Supplement 1): 10996–10997.
https://doi.org/10.1182/blood-2022-171146
Published: 2022
Journal Articles

Doxorubicin, Etoposide, Vinblastine and Dacarbazine (AEVD) for Newly Diagnosed Classic Hodgkin Lymphoma

Marcelo Pitombeira de Lacerda, Julio Cesar de Oliveira, Sergio Jungles, Jr., Gabriela Sirydakis Macedo, Ana Paula Tomazelli, Joao Pedro Ribeiro Baptista, Ana Claudia Dall'Oglio, Gabriela Roncone Gastal, Ivan Schneider Boettcher, Fabiana Sanchez Tavares, Soraya Dobner
Journal: Blood
Blood (2021) 138 (Supplement 1): 2473.
https://doi.org/10.1182/blood-2021-151485
Published: 2021
Journal Articles

Primary Care Physician-Based Telemedicine in Non-Malignant Hematology: Prospective Analysis of 790 Consecutive Cases

Kendra Lys Calixto Machado, Taina Araujo, Joao Pedro Ribeiro Baptista, Ivan Schneider Boettcher, Marcelo Pitombeira de Lacerda
Journal: Blood
Blood (2021) 138 (Supplement 1): 2973.
https://doi.org/10.1182/blood-2021-154100
Published: 2021